Page 9 - Includes Docubay News Today : Breaking News, Live Updates & Top Stories | Vimarsana

This week, two real estate companies announced that they have sold out their real estate projects. What was worth noting, the overall size of the project, time in which they were sold and the price point at which they were lapped up. Both, real estate prices and stocks of real estate have seen a revival for last three years, if above events are anything to go by than probably, it appears that the demand continues to be strong in some pockets. Given the fact that the operating matrix of the real estate industry is such that debt element will present, it would be worthwhile to stay with large pl...

While the desire to own small caps is high, it is very important to manage the risks of investing in them, they may either give very high returns or just make your capital under perform significantly. For enthusiasts and steadfast supporters of small-cap stocks, the key lies in a thorough examination of a company's fundamentals before making any investment decisions. Beyond these financial metrics, two critical aspects must not be overlooked: the quality of the company's management and the sector in which it operates. The management team's competence, integrity, and vision are pivotal in steer...

In the last few weeks, just because one bank has underperformed and was able to drag the market lower, that does not mean everything in one of the most important sectors of the economy, which is BFSI, is bad. This distinction needs to be made because in BFSI space every segment has a very different operating matrix and hence the growth path. So, while banks might be under pressure, AMCs have been doing well. Similarly, life insurers are under pressure but the general insurance companies have done well. So rather than a broad brush, have a look at companies individually for better decision-maki...

In the last three years, Novartis is the third MNC pharma company which has announced sale of a part of its business in India. Some of these restructuring are being done as part of the global readjustment being made at the parent companies level. The bigger question is whether after this restructuring will the MNC pharma stocks, which have been underperforming for quite some time, be able to make a comeback on the street or not. This answer to this question would depend on multiple factors. Right from the use of the sale proceeds to whether post restructuring focus would be on a 100 percent su...

Once again on wednesday, there was minor correction in nifty, but more tremors were felt in the mid-cap part of the market. While it might be too early to call it even a corrective move, because this could be due to profit booking just before the expiry of the weekly option contract today. But because volatility never gives notice before coming, it is better to be prepared for it, by staying with a set of stocks which have a higher probability when a storm hits the street. While there is no full proof way, putting some filter would help at least in avoiding some mistakes. So, staying with the ...